LunarCrush LLM | creator/twitter::1275846168178655233/posts

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@Enveric_Bio](/creator/twitter/Enveric_Bio)
"Enverics XXX patent includes claims that appear relevant to the Bretisilocin molecule currently in clinical trials which AbbVie agreed to acquire on August XX 2025 in a definitive transaction valued at up to $XXX billion. More info: $ENVB"  
[X Link](https://x.com/Enveric_Bio/status/1978465162710421636) [@Enveric_Bio](/creator/x/Enveric_Bio) 2025-10-15T14:17Z 3423 followers, XXX engagements


"Enverics lead product candidate EB-003 is protected by a different patent family which is separate and distinct from the patent that appears relevant to Bretisilocin the molecule recently acquired by AbbVie in a $XXX billion deal. More info: $ENVB"  
[X Link](https://x.com/Enveric_Bio/status/1978494903844794417) [@Enveric_Bio](/creator/x/Enveric_Bio) 2025-10-15T16:15Z 3423 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Enveric_Bio "Enverics XXX patent includes claims that appear relevant to the Bretisilocin molecule currently in clinical trials which AbbVie agreed to acquire on August XX 2025 in a definitive transaction valued at up to $XXX billion. More info: $ENVB"
X Link @Enveric_Bio 2025-10-15T14:17Z 3423 followers, XXX engagements

"Enverics lead product candidate EB-003 is protected by a different patent family which is separate and distinct from the patent that appears relevant to Bretisilocin the molecule recently acquired by AbbVie in a $XXX billion deal. More info: $ENVB"
X Link @Enveric_Bio 2025-10-15T16:15Z 3423 followers, XXX engagements